|
USP39 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.011600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.240100E-02 |
| Normal-vs-Stage2 |
4.015000E-01 |
| Normal-vs-Stage3 |
1.491560E-01 |
| Normal-vs-Stage4 |
8.259000E-01 |
| Stage1-vs-Stage2 |
6.645800E-01 |
| Stage1-vs-Stage3 |
1.701580E-03 |
| Stage1-vs-Stage4 |
2.050200E-01 |
| Stage2-vs-Stage3 |
8.150300E-02 |
| Stage2-vs-Stage4 |
4.743400E-01 |
| Stage3-vs-Stage4 |
5.385000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.267970E-01 |
| Normal-vs-AfricanAmerican |
3.415200E-01 |
| Normal-vs-Asian |
2.730400E-01 |
| Caucasian-vs-AfricanAmerican |
8.220800E-01 |
| Caucasian-vs-Asian |
2.212400E-01 |
| AfricanAmerican-vs-Asian |
2.776400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.730350E-02 |
| Normal-vs-Female |
1.640000E-01 |
| Male-vs-Female |
6.039500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.051610E-01 |
| Normal-vs-Extreme_Weight |
1.109980E-02 |
| Normal-vs-Obese |
9.617000E-01 |
| Normal-vs-Extreme_Obese |
3.487200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.026600E-01 |
| Normal_Weight-vs-Obese |
1.301400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.305600E-01 |
| Extreme_Weight-vs-Obese |
1.990020E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.688800E-01 |
| Obese-vs-Extreme_Obese |
2.824200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.122800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.841600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.212500E-02 |
| Normal-vs-Age(81-100Yrs) |
5.359900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.546650E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.023520E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.739890E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.107600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.393600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.157400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.087230E-01 |
| Normal-VS-Type2 PRCC |
8.047900E-02 |
| Normal-VS-KIRP CIMP |
1.397780E-02 |
| Normal-VS-Unclassified PRCC |
8.574000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.218400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.20230000000021E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
4.462000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.607800E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.790000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.340210E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.782800E-03 |
| Normal-vs-N1 |
6.593800E-02 |
| Normal-vs-N2 |
7.904200E-01 |
| N0-vs-N1 |
1.623800E-03 |
| N0-vs-N2 |
4.443200E-01 |
| N1-vs-N2 |
3.578400E-01 |
|
|
